Nowadays, cardiovascular disease may be a double-edged factor, since it is a proven risk factor for COVID-19 severity, but some of the treatments used, such as ACE inhibitors, have also proved to be protective against severe infections from SARS-CoV-2 [61,62]. Here, ACE is linked to COVID-19.